Novo Nordisk has updated its Wegovy savings program, allowing eligible cash-paying patients to access the drug at retail ...

Novo Nordisk NVO announced an update to the savings offer for its popular obesity injection, Wegovy (semaglutide). This ...

With a FDA deadline set for March 26 to stop compounding versions of Zepbound, followed by restrictions on compounded Ozempic ...

Novo Nordisk announced a direct-to-consumer program that allows patients to buy Wegovy out of pocket at a lower cost.

A healthcare professional will review your visit and schedule an in-depth consultation to determine eligibility. If Wegovy or another weight loss medication is appropriate, Ro will connect you ...

Wegovy is FDA approved for children ages 12 years and older who have obesity. Mounjaro is not approved for use in children under age 18 years. Review of studies: Here’s a brief look at whether ...

Note: After the FDA approves a drug, it tracks and reviews side effects of the medication. If you develop a side effect while taking Wegovy and want to tell the FDA about it, visit MedWatch.

Wegovy is also available through NovoCare Pharmacy, which directly ship all dose strengths at a cost of $499 per month for ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...

Novo Nordisk announced updates to the Wegovy® savings program, allowing all eligible cash-paying patients access to Wegovy® ...